{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T08:16:24Z","timestamp":1790410584565,"version":"4.1.0"},"update-to":[{"DOI":"10.1002\/14651858.cd010344","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T00:00:00Z","timestamp":1445904000000}}],"reference-count":76,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd010344.pub2","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T17:37:32Z","timestamp":1445967452000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Pharmacological interventions for the acute management of hyperkalaemia in adults"],"prefix":"10.1002","volume":"2015","author":[{"given":"Josh","family":"Batterink","sequence":"first","affiliation":[{"name":"Providence Health Care; Pharmacy; 1081 Burrard Street Vancouver BC Canada V6Z 1Y6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara A","family":"Cessford","sequence":"additional","affiliation":[{"name":"University of British Columbia; Internal Medicine; Providence Health Care St Paul's Hospital, 1081 Burrard Street Vancouver BC Canada V6Z 1Y6"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert AI","family":"Taylor","sequence":"additional","affiliation":[{"name":"Providence Health Care; Pharmacy; 1081 Burrard Street Vancouver BC Canada V6Z 1Y6"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,10,27]]},"reference":[{"issue":"1","key":"10.1002\/14651858.CD010344.pub2-BIB0001|cit1","first-page":"238","article-title":"Acute treatment of hyperkalemia in hemodialysis (HD) patients with nebulized albuterol [abstract]","volume":"35","author":"Allon","year":"1989","journal-title":"Kidney International"},{"issue":"6","key":"10.1002\/14651858.CD010344.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.7326\/0003-4819-110-6-426","article-title":"Nebulized albuterol for acute hyperkalemia in patients on hemodialysis","volume":"110","author":"Allon","year":"1989","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD010344.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/ki.1990.284","article-title":"Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients","volume":"38","author":"Allon","year":"1990","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD010344.pub2-BIB0004|cit4","first-page":"202","article-title":"Effect of intravenous salbutamol vs salbutamol in micronebulizator in the hyperkalemia due to chronic renal failure","volume":"19","author":"Balanzario","year":"2003","journal-title":"Medicina Interna de Mexico"},{"issue":"5","key":"10.1002\/14651858.CD010344.pub2-BIB0005|cit5","first-page":"276","article-title":"Intravenous infusion or nebulization of salbutamol for treatment of hyperkalemia in patients with chronic renal failure","volume":"53","author":"Liou","year":"1994","journal-title":"Chung Hua i Hsueh Tsa Chih [Chinese Medical Journal]"},{"key":"10.1002\/14651858.CD010344.pub2-BIB0006|cit6","first-page":"1082","article-title":"Comparison of aminophylline and insulin-dextrose infusions in acute therapy of hyperkalemia in end-stage renal disease patients","volume":"49","author":"Mahajan","year":"2001","journal-title":"Journal of the Association of Physicians of India"},{"issue":"3","key":"10.1002\/14651858.CD010344.pub2-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1378\/chest.115.3.617","article-title":"Salbutamol metered-dose inhaler with spacer for hyperkalemia: how fast? How safe?","volume":"115","author":"Mandelberg","year":"1999","journal-title":"Chest"},{"issue":"8","key":"10.1002\/14651858.CD010344.pub2-BIB0008|cit8","first-page":"503","article-title":"Treatment of hyperkalaemia by altering the transcellular gradient in patients with renal failure: effect of various therapeutic approaches","volume":"74","author":"Ngugi","year":"1997","journal-title":"East African Medical Journal"},{"issue":"1","key":"10.1002\/14651858.CD010344.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ki.1993.34","article-title":"Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia","volume":"43","author":"Allon","year":"1993","journal-title":"Kidney International"},{"issue":"4","key":"10.1002\/14651858.CD010344.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0272-6386(95)90597-9","article-title":"Effect of albuterol treatment on subsequent dialytic potassium removal","volume":"26","author":"Allon","year":"1995","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD010344.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/S0272-6386(96)90460-6","article-title":"Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol","volume":"28","author":"Allon","year":"1996","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD010344.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0002-9343(88)80086-X","article-title":"Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure","volume":"85","author":"Blumgerg","year":"1988","journal-title":"American Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD010344.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2217\/fca.11.71","article-title":"PEARL-HF: prevention of hyperkalemia in patients with heart failure using a novel polymeric potassium binder, RLY5016","volume":"8","author":"Buysse","year":"2012","journal-title":"Future Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD010344.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00000542-199304000-00010","article-title":"Insulin decreases the serum potassium concentration during the anhepatic stage of liver transplantation","volume":"78","author":"Wolf","year":"1993","journal-title":"Anesthesiology"},{"issue":"10","key":"10.1002\/14651858.CD010344.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1681\/ASN.V9101924","article-title":"Effect of single dose resin-cathartic therapy on serum potassium concentration in patients with end-stage renal disease","volume":"9","author":"Gruy-Kapral","year":"1998","journal-title":"Journal of the American Society of Nephrology"},{"issue":"6","key":"10.1002\/14651858.CD010344.pub2-BIB0016|cit16","first-page":"A161","article-title":"The combined regimen of bicarbonate and beta2-agonist (salbutamol) in acute therapy of hyperkalemia in hemodialysis patients [abstract]","volume":"11","author":"Kim","year":"1996","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"11","key":"10.1002\/14651858.CD010344.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1093\/ndt\/gfm386","article-title":"Effect of fludrocortisone acetate on reducing serum potassium levels in patients with end-stage renal disease undergoing haemodialysis","volume":"22","author":"Kim","year":"2007","journal-title":"Nephrology Dialysis Transplantation"},{"key":"10.1002\/14651858.CD010344.pub2-BIB0018|cit18","unstructured":"Lens XM Montoliu J Cases A Campistol JM Absence of synergistic effect between salbutamol (S) and aminophylline (A) for the treatment of hyperkalemia in renal failure [abstract] 24th Annual Congress. EDTA-ERA; 1987 Oct 25-29; West Berlin, Germany 1987 75"},{"issue":"3","key":"10.1002\/14651858.CD010344.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/oxfordjournals.ndt.a091860","article-title":"Treatment of hyperkalaemia in renal failure: salbutamol v. insulin","volume":"4","author":"Lens","year":"1989","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD010344.pub2-BIB0020|cit20","first-page":"623","article-title":"Treatment of hyperkalemia in renal failure: Salbutamol versus glucose and insulin [abstract]","volume":"32","author":"Lens","year":"1987","journal-title":"Kidney International"},{"issue":"2","key":"10.1002\/14651858.CD010344.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1136\/adc.70.2.126","article-title":"Treatment of hyperkalaemia using intravenous and nebulised salbutamol","volume":"70","author":"McClure","year":"1994","journal-title":"Archives of Disease in Childhood"},{"issue":"1","key":"10.1002\/14651858.CD010344.pub2-BIB0022|cit22","first-page":"39","article-title":"Inhaler salbutamol for acute hyperkalemia in renal failure","volume":"29","author":"Mocan","year":"1993","journal-title":"Israel Journal of Medical Science"},{"issue":"2","key":"10.1002\/14651858.CD010344.pub2-BIB0023|cit23","first-page":"176","article-title":"Treatment of hyperkalemia with salbutamol and insulin","volume":"22","author":"Mushtaq","year":"2006","journal-title":"Pakistan Journal of Medical Sciences"},{"issue":"1","key":"10.1002\/14651858.CD010344.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0736-4679(03)00133-1","article-title":"Levalbuterol is as effective as racemic albuterol in lowering serum potassium","volume":"25","author":"Pancu","year":"2003","journal-title":"Journal of Emergency Medicine"},{"issue":"7953","key":"10.1002\/14651858.CD010344.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0140-6736(76)91340-4","article-title":"Treatment of attacks in hyperkalaemic familial periodic paralysis by inhalation of salbutamol","volume":"307","author":"Wang","year":"1976","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD010344.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/jama.2015.7446","article-title":"Effect of patiromer on serum potassium level in patients with hyperkalemia and diabetic kidney disease: The AMETHYST-DN Randomized Clinical Trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD010344.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"A855","DOI":"10.1016\/S0735-1097(15)60855-5","article-title":"1-year safety and efficacy of patiromer for hyperkalemia in heart failure patients with chronic kidney disease on renin-angiotensin-aldosterone system inhibitors [abstract]","volume":"65","author":"Pitt","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD010344.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ki.2014.382","article-title":"A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient","volume":"88","author":"Ash","year":"2015","journal-title":"Kidney International"},{"issue":"12 Suppl 1","key":"10.1002\/14651858.CD010344.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"A369","DOI":"10.1016\/S0735-1097(14)60369-7","article-title":"ZS-9, a novel selective cation trap, leads to a rapid and predictable rate of decline in serum potassium in patients with chronic kidney disease and hyperkalemia [abstract]","volume":"63","author":"Singh","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010344.pub2-BIB0030|cit30","first-page":"iii155","article-title":"Acid-base balance in a phase 2 trial of ZS-9 for hyperkalaemia in patients with chronic kidney disease [abstract]","volume":"29","author":"Singh","year":"2014","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"1","key":"10.1002\/14651858.CD010344.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000358836","article-title":"Bolus administration of intravenous glucose in the treatment of hyperkalemia: a randomized controlled trial","volume":"126","author":"Chothia","year":"2014","journal-title":"Nephron. Physiology"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD010344.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"A842","DOI":"10.1016\/S0735-1097(15)60842-7","article-title":"Treatment of hyperkalemia with ZS-9, a selective nonabsorbed cation exchange resin, does not lead to hypomagnesemia: results from two multicenter, randomized, double blind, placebo-controlled phase 3 trials [abstract]","volume":"65","author":"El-Shahawy","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"issue":"21","key":"10.1002\/14651858.CD010344.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD010344.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"A54","DOI":"10.1053\/j.ajkd.2015.02.159","article-title":"Sodium zirconium cyclosilicate (ZS-9) for hyperkalemia in stage 4\/5 CKD subgroup of the phase 3 HARMONIZE study [abstract]","volume":"65","author":"Lerma","year":"2015","journal-title":"American Journal of Kidney Diseases"},{"issue":"5 Suppl 1","key":"10.1002\/14651858.CD010344.pub2-BIB0035|cit35","first-page":"S69","article-title":"Sodium zirconium cyclosilicate (ZS-9) for severe hyperkalemia: A post-HOC analysis of the phase 3 HARMONIZE trial [abstract]","volume":"22","author":"Peacock","year":"2015","journal-title":"Academic Emergency Medicine"},{"issue":"4","key":"10.1002\/14651858.CD010344.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"A69","DOI":"10.1053\/j.ajkd.2015.02.222","article-title":"Safety of sodium zirconium cyclosilicate (ZS-9) in hyperkalemia: Analysis of GI effects in the phase 3 HARMONIZE study [abstract]","volume":"65","author":"Qunibi","year":"2015","journal-title":"American Journal of Kidney Diseases"},{"issue":"4","key":"10.1002\/14651858.CD010344.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"A70","DOI":"10.1053\/j.ajkd.2015.02.223","article-title":"Sodium zirconium cyclosilicate (ZS-9) in hyperkalemic patients with CKD on RAAS inhibitors: Subgroup analysis of phase 3 HARMONIZE study [abstract]","volume":"65","author":"Qunibi","year":"2015","journal-title":"American Journal of Kidney Diseases"},{"key":"10.1002\/14651858.CD010344.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"e450","DOI":"10.1097\/01.hjh.0000468799.18826.ad","article-title":"Sodium zirconium cyclosilicate for treatment of hyperkalaemia: Analysis of patients on renin-angiotensin-aldosterone inhibitors (RAASi) from the phase 3 HARMONIZE study [abstract]","volume":"33","author":"Zannad","year":"2015","journal-title":"Journal of Hypertension"},{"key":"10.1002\/14651858.CD010344.pub2-BIB0039|cit39","first-page":"342","article-title":"Effect of sodium zirconium cyclosilicate (ZS-9) on aldosterone from the phase 3 randomized, double-blind, placebo-controlled HARMONIZE study [abstract]","volume":"17","author":"Zannad","year":"2015","journal-title":"European Journal of Heart Failure"},{"issue":"4","key":"10.1002\/14651858.CD010344.pub2-BIB0040|cit40","first-page":"455","article-title":"Treatment of hyperkalemia in patients with chronic kidney disease: a comparison of calcium polystyrene sulphonate and sodium polystyrene sulphonate","volume":"26","author":"Nasir","year":"2014","journal-title":"Journal of Ayub Medical College, Abbottabad: JAMC"},{"key":"10.1002\/14651858.CD010344.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ejhf.402","article-title":"Patiromer lowers serum potassium and prevents recurrent hyperkalemia in patients with heart failure and CKD when treated with RAAS inhibitors: Results from OPAL-HK [abstract]","volume":"17","author":"Pitt","year":"2015","journal-title":"European Journal of Heart Failure"},{"issue":"4","key":"10.1002\/14651858.CD010344.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"A90","DOI":"10.1053\/j.ajkd.2015.02.303","article-title":"Patiromer reduced recurrent hyperkalemia in advanced CKD patients on RAASI [abstract]","volume":"65","author":"Weir","year":"2015","journal-title":"American Journal of Kidney Diseases"},{"issue":"3","key":"10.1002\/14651858.CD010344.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD010344.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"A878","DOI":"10.1016\/S0735-1097(15)60878-6","article-title":"Acute-phase efficacy of ZS-9 in patients with baseline serum potassium levels above 5.5 MEQ\/l: Analysis from a phase 3, multicenter, randomized, double blind, placebo-controlled trial [abstract]","volume":"65","author":"El-Shahawy","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010344.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"iii178","DOI":"10.1093\/ndt\/gfu150","article-title":"Acute-phase efficacy in a phase 3 multicenter, randomised, double-blind, placebo-controlled trial of ZS-9 for hyperkalaemia [abstract]","volume":"29","author":"El-Shahawy","year":"2014","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010344.pub2-BIB0046|cit46","first-page":"722","article-title":"Maintenance of normal serum K+ with ZS-9 once daily in patients with CHF: Subgroup analysis of a phase 3 multicenter, randomised, double-blind placebo-controlled trial of patients with hyperkalaemia [abstract]","volume":"35","author":"El-Shahawy","year":"2014","journal-title":"European Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD010344.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1056\/NEJMoa1411487","article-title":"Sodium zirconium cyclosilicate in hyperkalemia","volume":"372","author":"Packham","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"10 Suppl 1","key":"10.1002\/14651858.CD010344.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"A792","DOI":"10.1016\/S0735-1097(15)60792-6","article-title":"ZS-9 maintains normokalemia in hyperkalemic patients despite continuing RAAS inhibitors: a subgroup analysis from a phase 3 multicenter, randomized, double blind, placebo-controlled trial [abstract]","volume":"65","author":"Qunibi","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD010344.pub2-BIB0049|cit49","first-page":"A142","article-title":"Once-daily ZS-9, a novel selective potassium trap, maintained normokalemia in patients with diabetes after acute therapy for hyperkalemia [abstract]","volume":"63","author":"Rasmussen","year":"2014","journal-title":"Diabetes"},{"key":"10.1002\/14651858.CD010344.pub2-BIB0050|cit50","first-page":"A296","article-title":"ZS-9, a novel selective potassium trap, rapidly reduced serum potassium in patients with diabetes treated for hyperkalemia [abstract]","volume":"63","author":"Rasmussen","year":"2014","journal-title":"Diabetes"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010344.pub2-BIB0051|cit51","first-page":"iii180","article-title":"Efficacy of ZS-9 in patients receiving RAAS therapy: a subgroup analysis of a phase 3 multicenter, randomised, double-blind, placebo-controlled trial [abstract]","volume":"29","author":"Roger","year":"2014","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010344.pub2-BIB0052|cit52","first-page":"iii182","article-title":"Extended efficacy of ZS-9 once-daily in a phase 3 multicenter, randomised, double-blind, placebo-controlled trial of patients with hyperkalaemia [abstract]","volume":"29","author":"Roger","year":"2014","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD010344.pub2-BIB0053|cit53","first-page":"A17489","article-title":"Phase 3, multicenter, randomized, double-blind, placebo-controlled trial of once-daily ZS-9 for treatment of hyperkalemia: achievement and maintenance of K+ in subgroup analysis of patients with heart failure not on RAAS inhibitors [abstract]","volume":"130","author":"Singh","year":"2014","journal-title":"Circulation"},{"issue":"Suppl 3","key":"10.1002\/14651858.CD010344.pub2-BIB0054|cit54","first-page":"iii178","article-title":"Phase 3, multicenter, randomised, double-blind, placebo-controlled trial of ZS-9: subgroup analysis stratified by baseline serum potassium levels [abstract]","volume":"29","author":"Singh","year":"2014","journal-title":"Nephrology Dialysis Transplantation"},{"issue":"4","key":"10.1002\/14651858.CD010344.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"A91","DOI":"10.1053\/j.ajkd.2015.02.309","article-title":"Placebo effect in clinical studies in hyperkalemia: A double-blind, randomized, placebo-controlled phase 3 study of sodium zirconium cyclosilicate (ZS-9) [abstract]","volume":"65","author":"Yang","year":"2015","journal-title":"American Journal of Kidney Diseases"},{"issue":"1","key":"10.1002\/14651858.CD010344.pub2-BIB0056|cit56","first-page":"50","article-title":"Efficacy of hyperK-cocktail versus regular insulin in the management of hyperkalemia","volume":"31","author":"Ramos-Penafiel","year":"2015","journal-title":"Medicina Interna de Mexico"},{"key":"10.1002\/14651858.CD010344.pub2-BIB0057|cit57","unstructured":"Rasmussen H Multicenter, multi-dose, open-label maintenance of long-term safety and efficacy of sodium zirconium cyclosilicate (ZS) in hyperkalemia, including a randomized, double-blind, placebo-controlled withdrawal clinicaltrials gov\/ct2\/show\/NCT02163499"},{"key":"10.1002\/14651858.CD010344.pub2-BIB0058|cit58","unstructured":"Alfonzo A Soar J MacTier R Fox J Shilliday I Nolan J Clinical practice guidelines. Treatment of acute hyperkalaemia in adults. 2014 www.renal.org\/docs\/default-source\/guidelines-resources\/joint-guidelines\/treatment-of-acute-hyperkalaemia-in-adults\/hyperkalaemia-guideline---march-2014.pdf?sfvrsn=2"},{"issue":"7420","key":"10.1002\/14651858.CD010344.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(66)90698-2","article-title":"Treatment of hyperkalemia with a calcium-resin","volume":"1","author":"Berlyne","year":"1966","journal-title":"Lancet"},{"issue":"6303","key":"10.1002\/14651858.CD010344.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1136\/bmj.283.6303.1366","article-title":"Hyperkalaemic cardiac arrhythmia caused by potassium citrate mixture","volume":"283","author":"Browning","year":"1981","journal-title":"British Medical Journal Clinical Research Ed"},{"issue":"4","key":"10.1002\/14651858.CD010344.pub2-BIB0061|cit61","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jcrc.2005.10.001","article-title":"Management of severe hyperkalemia without hemodialysis: case report and literature review","volume":"21","author":"Carvalhana","year":"2006","journal-title":"Journal of Critical Care"},{"issue":"2","key":"10.1002\/14651858.CD010344.pub2-BIB0062|cit62","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003235.pub2","article-title":"Emergency interventions for hyperkalaemia","author":"Mahoney","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD010344.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1177\/0885066605278969","article-title":"Hyperkalemia: a review","volume":"20","author":"Evans","year":"2005","journal-title":"Journal of Intensive Care Medicine"},{"issue":"2","key":"10.1002\/14651858.CD010344.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1093\/bja\/70.2.226","article-title":"Muscular paralysis and ventilatory failure caused by hyperkalaemia","volume":"70","author":"Freeman","year":"1993","journal-title":"British Journal of Anaesthesia"},{"issue":"1","key":"10.1002\/14651858.CD010344.pub2-BIB0065|cit65","first-page":"46","article-title":"Hyperkalemia: treatment options","volume":"18","author":"Greenberg","year":"1998","journal-title":"Seminars in Nephrology"},{"issue":"7414","key":"10.1002\/14651858.CD010344.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD010344.pub2-BIB0067|cit67","unstructured":"Higgins JP Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"2","key":"10.1002\/14651858.CD010344.pub2-BIB0068|cit68","first-page":"283","article-title":"Hyperkalemia","volume":"73","author":"Hollander-Rodriguez","year":"2006","journal-title":"American Family Physician"},{"issue":"6","key":"10.1002\/14651858.CD010344.pub2-BIB0069|cit69","first-page":"266","article-title":"Sodium polystyrene sulfonate resin candy for control of potassium in chronic dialysis patients","volume":"5","author":"Johnson","year":"1976","journal-title":"Clinical Nephrology"},{"issue":"4","key":"10.1002\/14651858.CD010344.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/emj.2003.013599","article-title":"Agreement between an arterial blood gas analyser and a venous blood analyser in the measurement of potassium in patients in cardiac arrest","volume":"22","author":"Johnston","year":"2005","journal-title":"Emergency Medicine Journal"},{"key":"10.1002\/14651858.CD010344.pub2-BIB0071|cit71","unstructured":"McVeigh G Maxwell P O'Donnell S Guidelines for the treatment of hyperkalemia in adults. Guidelines and Audit Implementation Network, 2014 www.gain-ni.org\/images\/Uploads\/Guidelines\/GAIN_Guidelines_Treatment_of_Hyperkalaemia_in_Adults_GAIN_02_12_2014.pdf"},{"issue":"5","key":"10.1002\/14651858.CD010344.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1525-139X.2007.00312.x","article-title":"Management of hyperkalemia in dialysis patients","volume":"20","author":"Putcha","year":"2007","journal-title":"Seminars in Dialysis"},{"issue":"3","key":"10.1002\/14651858.CD010344.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1177\/000331977802900302","article-title":"Potassium-related cardiac arrhythmias and their treatment","volume":"29","author":"Schwartz","year":"1978","journal-title":"Angiology"},{"issue":"13","key":"10.1002\/14651858.CD010344.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJM198503283121304","article-title":"Catecholamine modulation of rapid potassium shifts during exercise","volume":"312","author":"Williams","year":"1985","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD010344.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2337\/diab.36.9.1035","article-title":"Insulin hyperpolarizes rat myotube primary culture without stimulating glucose uptake","volume":"36","author":"Zierler","year":"1987","journal-title":"Diabetes"},{"issue":"2","key":"10.1002\/14651858.CD010344.pub2-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010344","article-title":"Pharmacological interventions for treating acute hyperkalaemia in adults","author":"Batterink","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD010344.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T11:41:45Z","timestamp":1666093305000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD010344.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Kidney and Transplant Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,10,27]]},"references-count":76,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2015,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd010344.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,27]]}}}